Results 181 to 190 of about 72,473 (300)

Sex Differences in Associations of Lewy Body Disease with Alzheimer's Disease and Cognitive Decline. [PDF]

Ann Neurol
Wood Alexander M, Fischer DL, VandeVrede L, Nichols E, Yu L, Pike JR, Swardfager W, Wu CY, Masellis M, Galea LAM, Zukotynski K, Einstein G, Black SE, Barnes LL, Schneider JA, Arvanitakis Z, Casaletto KB, Rabin JS.   +17 more
europepmc   +1 more source

Altered peripheral CRY1 gene expression may contribute to both organic and functional gastrointestinal disease

Experimental Physiology, EarlyView.
ABSTRACT Gastrointestinal conditions such as irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD) are characterized by alterations in physiological and immune functions. Given the circadian clock influences gastrointestinal physiology and immunity, we hypothesized that the peripheral circadian clock is altered in these patients and ...
Sophie Fowler, Gemma M. Paech, Emily C. Hoedt, Jennifer C. Pryor, Cheenie Nieva, Jessica K. Bruce, Prema M. Nair, Guy D. Eslick, Simonne Sherwin, Peter Pockney, Nicholas J. Talley, Grace L. Burns, Simon Keely   +12 more
wiley   +1 more source

Minor Visual Phenomena in Lewy Body Disease: A Systematic Review. [PDF]

Biomedicines
Capogna E, Pollarini V, Quinzi A, Guidi L, Sambati L, Criante MS, Mengoli E, Venneri A, Lodi R, Tonon C, Mitolo M.   +10 more
europepmc   +1 more source

Sex‐Based Differences in Noncommunicable Diseases in Older Adults: Raising the Profile of Older Females

Journal of the American Geriatrics Society, EarlyView.
Aathmika Nandan, Joyce M. Li, Paula A. Rochon   +2 more
wiley   +1 more source

Cost‐effectiveness and impact at scale of collaborative care and lecanemab for Alzheimer's disease

Alzheimer's &Dementia: Behavior &Socioeconomics of Aging, Volume 2, Issue 1, March 2026.
Abstract INTRODUCTION Advancements in disease‐modifying therapies and collaborative dementia care programs have created opportunities to transform care for people with Alzheimer's disease. METHODS We modeled people aged 71 across three scenarios: 18 months of lecanemab, collaborative care, and combined interventions.
Kelly J. Atkins, James G. Kahn, Katherine L. Possin   +2 more
wiley   +1 more source

Hypometabolic mismatch with atrophy and tau pathology in mixed Alzheimer's and Lewy body disease. [PDF]

Brain
Duong MT, Das SR, Khandelwal P, Lyu X, Xie L, McGrew E, Dehghani N, McMillan CT, Lee EB, Shaw LM, Yushkevich PA, Wolk DA, Nasrallah IM.   +12 more
europepmc   +1 more source

Characterizing Alzheimer’s Disease and Related Dementia in a Hypertension Population Within the State of Florida Using Electronic Health Record–Based Data

Clinical Pharmacology &Therapeutics, Volume 119, Issue 3, Page 751-762, March 2026.
Hypertension is a known modifiable risk factor for Alzheimer’s disease and related dementia (ADRD). However, it is unknown how variance in hypertension control, antihypertensive medications, and social determinants of health, such as social deprivation index (SDI), influence the risk of developing ADRD.
Eissa A. Jafari, Mona Alshahawey, Muhammad A. Zaman, Steven M. Smith, Yan Gong, Glenn E. Smith, Caitrin W. McDonough   +6 more
wiley   +1 more source

Associations of living alone and loneliness with neuropsychiatric symptoms in individuals with mild cognitive impairment: A retrospective cross‐sectional study

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 1, March 2026.
Abstract Aim Living alone and loneliness are recognized risk factors for neuropsychiatric symptoms in older adults. However, the distinct of the objective condition of living alone and subjective loneliness on specific neuropsychiatric symptoms in individuals with mild cognitive impairment (MCI) remains unclear.
Kayo Takeda, Hideki Kanemoto, Takashi Suehiro, Yuto Satake, Daiki Taomoto, Shigeki Katakami, Kenji Yoshiyama, Manabu Ikeda   +7 more
wiley   +1 more source

RETRACTION: α-Synuclein Conformational Antibodies Fused to Penetratin are Effective in Models of Lewy Body Disease. [PDF]

Ann Clin Transl Neurol
europepmc   +1 more source

Sialylation patterns in cerebral amyloid angiopathy

Brain Pathology, Volume 36, Issue 2, March 2026.
This study is the first to localize and evaluate sialylation modifications in the context of Alzheimer's Disease and Cerebral Amyloid Angiopathy, revealing a unique disease‐specific increase in intravascular sialylation. Abstract Glycosylation is the most common form of post‐translational modification in the brain and becomes significantly altered in ...
Caitlyn Fastenau, Rebecca Crisp, Mallory Keating, Elizabeth Ochoa, Timothy E. Richardson, Margaret E. Flanagan, Jamie M. Walker, Sarah C. Hopp, Kevin F. Bieniek   +8 more
wiley   +1 more source